239 related articles for article (PubMed ID: 1393263)
1. Effect of MgATP on pinacidil-induced displacement of glibenclamide from the sulphonylurea receptor in a pancreatic beta-cell line and rat cerebral cortex.
Schwanstecher M; Brandt C; Behrends S; Schaupp U; Panten U
Br J Pharmacol; 1992 Jun; 106(2):295-301. PubMed ID: 1393263
[TBL] [Abstract][Full Text] [Related]
2. Possible involvement of protein phosphorylation in the regulation of the sulphonylurea receptor of a pancreatic beta-cell line, HIT T15.
Niki I; Ashcroft SJ
Biochim Biophys Acta; 1991 Dec; 1133(1):95-101. PubMed ID: 1836360
[TBL] [Abstract][Full Text] [Related]
3. The binding properties of the solubilized sulfonylurea receptor from a pancreatic B-cell line are modulated by the Mg(++)-complex of ATP.
Schwanstecher M; Behrends S; Brandt C; Panten U
J Pharmacol Exp Ther; 1992 Aug; 262(2):495-502. PubMed ID: 1501109
[TBL] [Abstract][Full Text] [Related]
4. Characterization and solubilization of the sulphonylurea receptor in rat brain.
Niki I; Ashcroft SJ
Neuropharmacology; 1993 Oct; 32(10):951-7. PubMed ID: 8295717
[TBL] [Abstract][Full Text] [Related]
5. Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits.
Löffler-Walz C; Hambrock A; Quast U
Mol Pharmacol; 2002 Feb; 61(2):407-14. PubMed ID: 11809866
[TBL] [Abstract][Full Text] [Related]
6. The binding site for [3H]glibenclamide in the rat cerebral cortex does not recognize K-channel agonists or antagonists other than sulphonylureas.
Angel I; Bidet S
Fundam Clin Pharmacol; 1991; 5(2):107-15. PubMed ID: 1649112
[TBL] [Abstract][Full Text] [Related]
7. The binding properties of the particulate and solubilized sulfonylurea receptor from cerebral cortex are modulated by the Mg2+ complex of ATP.
Schwanstecher M; Schaupp U; Löser S; Panten U
J Neurochem; 1992 Oct; 59(4):1325-35. PubMed ID: 1402884
[TBL] [Abstract][Full Text] [Related]
8. Adenine nucleotide-induced inhibition of binding of sulphonylureas to their receptor in pancreatic islets.
Schwanstecher M; Löser S; Brandt C; Scheffer K; Rosenberger F; Panten U
Br J Pharmacol; 1992 Mar; 105(3):531-4. PubMed ID: 1628141
[TBL] [Abstract][Full Text] [Related]
9. Characterization of K(ATP)-channels in rat basilar and middle cerebral arteries: studies of vasomotor responses and mRNA expression.
Jansen-Olesen I; Mortensen CH; El-Bariaki N; Ploug KB
Eur J Pharmacol; 2005 Oct; 523(1-3):109-18. PubMed ID: 16226739
[TBL] [Abstract][Full Text] [Related]
10. Binding and effect of K ATP channel openers in the absence of Mg2+.
Russ U; Lange U; Löffler-Walz C; Hambrock A; Quast U
Br J Pharmacol; 2003 May; 139(2):368-80. PubMed ID: 12770942
[TBL] [Abstract][Full Text] [Related]
11. Mg2+ and ATP dependence of K(ATP) channel modulator binding to the recombinant sulphonylurea receptor, SUR2B.
Hambrock A; Löffler-Walz C; Kurachi Y; Quast U
Br J Pharmacol; 1998 Oct; 125(3):577-83. PubMed ID: 9806343
[TBL] [Abstract][Full Text] [Related]
12. Phosphate and thiophosphate group donating adenine and guanine nucleotides inhibit glibenclamide binding to membranes from pancreatic islets.
Schwanstecher M; Löser S; Rietze I; Panten U
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):83-9. PubMed ID: 1903188
[TBL] [Abstract][Full Text] [Related]
13. The molecular interaction of sulfonylureas with beta-cell ATP-sensitive K(+)-channels.
Kramer W; Müller G; Girbig F; Gutjahr U; Kowalewski S; Hartz D; Summ HD
Diabetes Res Clin Pract; 1995 Aug; 28 Suppl():S67-80. PubMed ID: 8529521
[TBL] [Abstract][Full Text] [Related]
14. The beta-cell glibenclamide receptor is an ADP-binding protein.
Niki I; Nicks JL; Ashcroft SJ
Biochem J; 1990 Jun; 268(3):713-8. PubMed ID: 2114099
[TBL] [Abstract][Full Text] [Related]
15. Lipids modulate ligand binding to sulphonylurea receptors.
Klein A; Lichtenberg J; Stephan D; Quast U
Br J Pharmacol; 2005 Aug; 145(7):907-15. PubMed ID: 15895108
[TBL] [Abstract][Full Text] [Related]
16. Effects of Troglitazone (CS-045) on insulin secretion in isolated rat pancreatic islets and HIT cells: an insulinotropic mechanism distinct from glibenclamide.
Masuda K; Okamoto Y; Tsuura Y; Kato S; Miura T; Tsuda K; Horikoshi H; Ishida H; Seino Y
Diabetologia; 1995 Jan; 38(1):24-30. PubMed ID: 7744225
[TBL] [Abstract][Full Text] [Related]
17. Interaction of N-benzoyl-D-phenylalanine and related compounds with the sulphonylurea receptor of beta-cells.
Schwanstecher C; Meyer M; Schwanstecher M; Panten U
Br J Pharmacol; 1998 Mar; 123(6):1023-30. PubMed ID: 9559882
[TBL] [Abstract][Full Text] [Related]
18. The mitochondrial sulfonylurea receptor: identification and characterization.
Szewczyk A; Wójcik G; Lobanov NA; Nałecz MJ
Biochem Biophys Res Commun; 1997 Jan; 230(3):611-5. PubMed ID: 9015372
[TBL] [Abstract][Full Text] [Related]
19. Interaction of a novel dihydropyridine K+ channel opener, A-312110, with recombinant sulphonylurea receptors and KATP channels: comparison with the cyanoguanidine P1075.
Felsch H; Lange U; Hambrock A; Löffler-Walz C; Russ U; Carroll WA; Gopalakrishnan M; Quast U
Br J Pharmacol; 2004 Apr; 141(7):1098-105. PubMed ID: 15023854
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta.
Löffler C; Quast U
Br J Pharmacol; 1997 Feb; 120(3):476-80. PubMed ID: 9031752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
